Otto Kamp

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

The complexities of skeletal biology

Ratio of left ventricular peak E-wave velocity to flow propagation velocity assessed by color M-mode Doppler echocardiography in first myocardial infarction

Prognostic value of left atrial volume index in patents with first acute myocardial infarction

Microbubbles in ultrasound-triggered drug and gene delivery

Suppression of paroxysmal atrial tachyarrhythmias ? results of the SOPAT trial

Clinical and future applications of high intensity focused ultrasound in cancer

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation

Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

Ultrasonically triggered drug delivery: Breaking the barrier

Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure

Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

Amiodarone versus Sotalol for Atrial Fibrillation

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

Contrast echocardiography

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

Exercise Standards for Testing and Training

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation Results of a prospective and controlled study

Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction

E/e′ Two Weeks after Onset Is a Powerful Predictor of Cardiac Death and Heart Failure in Patients with a First-Time ST Elevation Acute Myocardial Infarction

Long-Term Quality of Life After Ablation of Atrial Fibrillation

Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation

Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials

Spinal gene transfer using ultrasound and microbubbles

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill-in-the-Pocket” Approach

Management of atrial fibrillation in patients with heart failure

Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Rate or rhythm control in persistent atrial fibrillation?

Color M-mode and pulsed wave tissue Doppler echocardiography: Powerful predictors of cardiac events after first myocardial infarction

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation

Evolution of a designed protein assembly encapsulating its own RNA genome

3D Echocardiography: A Review of the Current Status and Future Directions

Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists

Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)†

Use of three-dimensional speckle tracking to assess left ventricular myocardial mechanics: inter-vendor consistency and reproducibility of strain measurements

Long-term prognostic significance of left atrial volume in acute myocardial infarction

Sex and gender: modifiers of health, disease, and medicine

The importance of selenium to human health

The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

Rationale and current perspective for early rhythm control therapy in atrial fibrillation

Ultrasound microbubble induced endothelial cell permeability

Atrial fibrillation

Moderate physical exercise: a simplified approach for ventricular rate control in older patients with atrial fibrillation

Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy

Timing of thromboembolic events after electical cardioversion of atrial fibrillation or flutter: a retrospective analysis

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Mitral flow derived Doppler indices of left ventricular diastolic function in a general population. The Tromsø study

Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Role of left atrial appendageobliteration in stroke reductionin patients with mitral valve prosthesis

Pseudonormal and restrictive filling patterns predict left ventricular dilation and cardiac death after a first myocardial infarction: a serial color M-mode doppler echocardiographic study

Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

Restrictive Filling Pattern is a Powerful Predictor of Heart Failure Events Postacute Myocardial Infarction and in Established Heart Failure: A Literature-Based Meta-Analysis

Antithrombotic Therapy in Atrial Fibrillation

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation

Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

Clinical and quantitative coronary angiographic predictors of coronary restenosis

A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure

Validation of High Gradient Magnetic Field Based Drug Delivery to Magnetizable Implants Under Flow

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

The Metabolic Syndrome, Cardiopulmonary Fitness, and Subcutaneous Trunk Fat as Independent Determinants of Arterial Stiffness

Electrical, contractile and structural remodeling during atrial fibrillation

Myocardial Reperfusion Injury

Noninvasive estimation of left ventricular filling pressure by e/e′ is a powerful predictor of survival after acute myocardial infarction

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

Postconditioning for protection of the infarcting heart

Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic

Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: A pilot study

What We Talk About When We Talk About Fat

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

Current issues in reperfusion therapy

Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias

American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy

A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation

Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography

Beta-blockers for hypertension

Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve-inferior vena cava isthmus? Results of a multicentre randomised controlled trial

Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year

Incremental Prognostic Value of Novel Left Ventricular Diastolic Indexes for Prediction of Clinical Outcome in Patients With ST-Elevation Myocardial Infarction

Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*

Expert consensus document on arterial stiffness: methodological issues and clinical applications

A practical guide to assessment of ventricular diastolic function using doppler echocardiography

Augmented single‐unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation

Pharmacological rate control of atrial fibrillation

Structural and Functional Remodeling of the Left Atrium

Management of atrial fibrillation in patients with heart failure

Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction

Crucial factors and emerging concepts in ultrasound-triggered drug delivery

Phase‐shift, stimuli‐responsive perfluorocarbon nanodroplets for drug delivery to cancer

Antithrombotic Therapy in Atrial Fibrillation

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography

Usefulness of Left Ventricular Conic Index Measured by Real-Time Three-Dimensional Echocardiography to Predict Left Ventricular Remodeling After Acute Myocardial Infarction

Evaluation of left ventricular structure and function by three-dimensional echocardiography

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

3d Transition Metals for C–H Activation

Diagnosis and Management of the Metabolic Syndrome

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

A Noninvasive Method for Assessing Impaired Diastolic Suction in Patients With Dilated Cardiomyopathy

The Effects of Growth Hormone Replacement Therapy on Bone Metabolism in Adult-Onset Growth Hormone Deficiency: A 2-Year Open Randomized Controlled Multicenter Trial

Stiffness of Capacitive and Conduit Arteries

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Enhancement of the Cytotoxicity and Selectivity of Doxorubicin to Hepatoma Cells by Synergistic Combination of Galactose-Decorated γ-Poly(glutamic acid) Nanoparticles and Low-Intensity Ultrasound

Left Atrial Volume

Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy

Incremental Value of Left Ventricular Systolic and Diastolic Function to Determine Outcome in Patients with Acute ST‐Segment Elevation Myocardial Infarction: The Echocardiographic Substudy of the OASIS‐6 Trial

Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

Management of growth hormone deficiency in adults

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Destruction of Contrast Microbubbles by Ultrasound

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

Contraste ecocardiográfico y seguridad clínica

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Lifetime Risk for Development of Atrial Fibrillation

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Guidelines for the Primary Prevention of Stroke

C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals

Nanotechnology for Multimodal Synergistic Cancer Therapy

Nanoparticles in Photodynamic Therapy

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Moving the Tipping Point

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Beta-blockers for hypertension

Increased Central Artery Stiffness in Impaired Glucose Metabolism and Type 2 Diabetes

Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

Contrast Echocardiography and Clinical Safety

Pathological Ventricular Remodeling

Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease

Left Atrial Dysfunction in Patients With Atrial Fibrillation After Successful Rhythm Control for > 3 Months

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Fibrosis — A Common Pathway to Organ Injury and Failure

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Reactive Oxygen Species (ROS)-Based Nanomedicine

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications

Microbubble Administration Accelerates Clot Lysis During Continuous 2-MHz Ultrasound Monitoring in Stroke Patients Treated With Intravenous Tissue Plasminogen Activator

Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Free Radicals in the Physiological Control of Cell Function

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Atrial fibrillation: cure or treat?

Incidence, Pathophysiology, and Treatment of Complications During Dobutamine-Atropine Stress Echocardiography

Atrial Myocardial Deformation Properties Predict Maintenance of Sinus Rhythm After External Cardioversion of Recent-Onset Lone Atrial Fibrillation

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat

Effects of the Long-Term Administration of Nebivolol on the Clinical Symptoms, Exercise Capacity, and Left Ventricular Function of Patients with Diastolic Dysfunction: Results of the ELANDD Study

Contrast-enhanced versus non-enhanced three-dimensional echocardiography of left ventricular volumes

Hemodynamic Benefits of Right Ventricular Outflow Tract Pacing: Comparison with Right Ventricular Apex Pacing

Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RAte Control versus Electrical cardioversion (RACE) study

Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice

Left atrial appendage blood flow determined by transesophageal echocardiography in healthy subjects

Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion off atrial fibrillation

Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarction

Myocardial Contrast Echocardiography for the Detection of Coronary Artery Stenosis

Lenient versus Strict Rate Control in Patients with Atrial Fibrillation

Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography

Ultrasound and Microbubble-Induced Intra- and Intercellular Bioeffects in Primary Endothelial Cells

Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction

Intravenous myocardial contrast echocardiography predicts left ventricular remodeling in patients with acute myocardial infarction

Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life

Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: Results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study

Prediction of Improvement of Contractile Function in Patients With Ischemic Ventricular Dysfunction After Revascularization by Fluorine-18 Fluorodeoxyglucose Single-Photon Emission Computed Tomography

Mechanical dyssynchrony by 3D echo correlates with acute haemodynamic response to biventricular pacing in heart failure patients

Prognostic Implications of Restrictive Left Ventricular Filling in Acute Myocardial Infarction: A Serial Doppler Echocardiographic Study 11To discuss this article on-line, visit the ACC Home Page at www.acc.org/membersand click on the JACC Forum

Real‐Time Perfusion Imaging: A New Echocardiographic Technique for Simultaneous Evaluation of Myocardial Perfusion and Contraction

Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion

Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris

The use of contrast echocardiography for the detection of cardiac shunts

Reliability of left ventricular volumes and function measurements using three-dimensional speckle tracking echocardiography

Quantification of left ventricular volumes and ejection fraction using freehand transthoracic three-dimensional echocardiography: Comparison with magnetic resonance imaging

RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II

A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation

Microbubbles and ultrasound: from diagnosis to therapy

Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide

Adverse reactions to ultrasound contrast agents: Is the risk worth the benefit?

Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation

Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation ? results from the RAte Control versus Electrical cardioversion (RACE) study

Determinants of brachial artery mean 24 h pulse pressure in individuals with Type II diabetes mellitus and untreated mild hypertension

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation

NC100100, a new echo contrast agent for the assessment of myocardial perfusion—safety and comparison with technetium‐99m sestamibi single‐photon emission computed tomography in a randomized multicenter study

Long-Term Effects of Growth Hormone (GH) Replacement in Men with Childhood-Onset GH Deficiency¹

Structural Abnormalities of the Inferoseptal Left Ventricular Wall Detected by Cardiac Magnetic Resonance Imaging in Carriers of Hypertrophic Cardiomyopathy Mutations

Long-term Implications of Reocclusion on Left Ventricular Size and Function After Successful Thrombolysis for First Anterior Myocardial Infarction

Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.

Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status

Prediction of Restenosis After Coronary Balloon Angioplasty

Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation

Nebivolol

Prominent Crypt Formation in the Inferoseptum of a Hypertrophic Cardiomyopathy Mutation Carrier Mimics Noncompaction Cardiomyopathy

Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T

Determinants of brachial artery mean 24 h pulse pressure in individuals with Type II diabetes mellitus and untreated mild hypertension

Assessment of Myocardial Reperfusion by Intravenous Myocardial Contrast Echocardiography and Coronary Flow Reserve After Primary Percutaneous Transluminal Coronary Angiography in Patients With Acute Myocardial Infarction